Proof of Concept (PoC) Development for Biotech Startups
AI-assisted, cloud-native PoC prototypes built in weeks
Investor-Ready Prototypes for Biotech
Vision Shaping
-
Step 1
We help scope and prioritize functionality, define what the prototype must demonstrate, and align scientific hypotheses with technical execution.
Prototype Engineering
-
Step 2
Using modern AI, generative AI, and cloud-native architectures, we design and build an executable product prototype in weeks.
Raising Investment
-
Step 3
We help you prepare the pitch and support fundraising as a technology partner.
Vision Shaping
-
Step 1
We help scope and prioritize functionality, define what the prototype must demonstrate, and align scientific hypotheses with technical execution.
Prototype Engineering
-
Step 2
Using modern AI, generative AI, and cloud-native architectures, we design and build an executable product prototype in weeks.
Raising Investment
-
Step 3
We help you prepare the pitch and support fundraising as a technology partner.
What Founders Say After Raising with Us
AI dermatology software platform for automated skin condition diagnosis and personalized skincare treatment.
«The collaboration was seamless!»
All our needs were addressed in a very professional manner.
Yoanna Gouchtchina
CEO, Quantum SkinAI & Machine Learning, Cloud & Platform Architecture, Compliance & Production Readiness
Services
$5k–$10k
Prototype budget
$1.2M
Seed raised after prototype demo
USA
Location
We engineer product prototypes built specifically for fundraising
2-3M$
Average amount of raised capital by startups we supportedMost biotech startups pitch decks, hypotheses, and promises – and then wonder why fundraising drags on for months.
78%
Startups eventually fail yearly (high baseline risk if you stay at “idea + slides” too long)Forbes Advisor
35%
Software engineering time saved in practice with generative AI todayBain & Company
25%
Cost savings overall using generative AI – indicating real ROI potential beyond coding aloneMaster of Code Analytics
Build a prototype investors can evaluate
We help biotech founders turn abstract ideas into investor-facing product prototypes – engineered to demonstrate feasibility, execution, and technical credibility in fundraising conversations.
